MedPath

Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graft Function

Not Applicable
Conditions
Acute Kidney Injury
Delayed Graft Function
Kidney Transplantation
Glomerular Filtration Rate
Interventions
Other: Remote ischemic conditioning
Registration Number
NCT01395719
Lead Sponsor
University of Aarhus
Brief Summary

The purpose of this study is to determine whether remote ischemic conditioning can improve the outcome after renal transplantation with deceased donor. Remote ischemic conditioning is performed on the patient receiving a kidney from a deceased donor. Remote ischemic conditioning is done during the operation by inflating a tourniquet on the patients leg before opening the blood circulation to the kidney. The study focus on both the immediate kidney function after the transplantation, but also on the extended kidney function one year after the transplantation.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
220
Inclusion Criteria
  • Age 18 and above
  • Received information, signed consent
  • Candidate for kidney transplantation from deceased donor
Read More
Exclusion Criteria
  • Can't give informed consent
  • AV-fistula in the leg opposite the site where the graft will be placed
  • Threatening ischemia in the leg
  • If donor is a small child
  • If the patient receives a double transplant
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Remote ischemic conditioning (rIC)Remote ischemic conditioningPatients receiving kidney transplantation from a deceased donor. This group receives remote ischemic conditioning by inflating a tourniquet on the leg during surgery, before reperfusion of the kidney.
Primary Outcome Measures
NameTimeMethod
Time to a 50% drop in baseline plasma-creatinineminimum 1 week

Plasma-creatinine changes posttransplant will be described using an exponential/logistic/linear model depending on the individual patient data. All plasma-creatinine values 30 days posttransplant, or in case of temporary posttransplant dialysis 30 days after the last performed dialysis, will be used, measured minimum twice daily initially. Baseline plasma-creatinine is measured approximately 1 hour prior to reperfusion of the kidney. Time to a 50% drop in baseline plasma-creatinine will be estimated.

Secondary Outcome Measures
NameTimeMethod
GFR after 1 year12 months

GFR measurement by Cr-EDTA.

Need for dialysis1 week

Trial Locations

Locations (4)

University Medical Center Groningen

πŸ‡³πŸ‡±

Groningen, Netherlands

Division of Transplant Surgery, Erasmus MC, University Medical Center

πŸ‡³πŸ‡±

Rotterdam, Netherlands

Sahlgrenska Transplant Institute, Sahlgrenska Academy at the University of Gothenborg

πŸ‡ΈπŸ‡ͺ

Gothenburg, Sweden

Dept. of Renal Medicine, Aarhus University Hospital, Skejby

πŸ‡©πŸ‡°

Aarhus N, Denmark

Β© Copyright 2025. All Rights Reserved by MedPath